Showing 1341-1350 of 1922 results for "".
Positioning Yourself for Career Longevity
https://modernod.com/topics/business/positioning-yourself-for-career-longevity/38629/Tips to help you prevent and alleviate musculoskeletal disorders.New Drugs for Dry Eye and Demodex Blepharitis
https://modernod.com/topics/ocular-surface/new-drugs-for-dry-eye-and-idemodexi-blepharitis/38625/More options, more personalized treatment for patients. Get familiar with what may end up in your toolbox.A Closer Look at Ocular Aesthetic Offerings
https://modernod.com/topics/business/a-closer-look-at-ocular-aesthetic-offerings/38621/Uncovering the aesthetic benefits of various devices, eye beauty trends, and products.The Era of Retina Disease Treatment Options?
https://modernod.com/articles/significant-findings/the-era-of-retina-disease-treatment-options/37739/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatPotential Treatment Found for Age and Diabetes-Induced Eye Disease
https://modernod.com/articles/significant-findings/potential-treatment-found-for-age-and-diabetes-induced-eye-disease/37735/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatEyenovia Celebrates First FDA Approval
https://modernod.com/articles/significant-findings/eyenovia-celebrates-first-fda-approval/37736/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatDry Eye Market Heating Up
https://modernod.com/articles/significant-findings/dry-eye-market-heating-up/37737/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatFDA Flags Improperly Marketed Amniotic Fluid Eye Drops
https://modernod.com/articles/significant-findings/fda-flags-improperly-marketed-amniotic-fluid-eye-drops/37734/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatNew TFOS Workshop Report Available
https://modernod.com/articles/significant-findings/new-tfos-workshop-report-available/37733/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatUnderstanding Ocular Metastatic Tumors and Simulating Lesions
https://modernod.com/mod-issues/2023-apr/understanding-ocular-metastatic-tumors-and-simulating-lesions/38611/Knowing how to identify these metastases enables easy coordination of care with the patient’s oncologist or primary care provider.